Lipocine Inc.
Pharmaceutical Preparations · Salt Lake City, United States
- PrincipalsMahesh V. PatelChief Executive Officerand 1 more
- CompanyLipocine Inc.Salt Lake City, United States
- Phone line+1 (801) 994-7383General business
Lipocine Inc. is an SEC-registered Nasdaq-listed company (ticker LPCN) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Chief executive
Mahesh V. PatelChief Executive Officer
Everyone else on file (1)
Krista FogartyPrincipal Accounting Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Mahesh V. Patel — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Krista Fogarty — Principal Accounting Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Cannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityZai Lab LtdPharmaceutical Preparations · Shanghai1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capability